Radioiodine (I-131) therapy and the incidence of hypothyroidism

Annals of the Academy of Medicine Singapore

Volumn 26, Issue 1, 1997, Pages 128-131

  Tavintharan, S ^a   Sundram, F X ^b   Chew, L S ^a  

^a ALEXANDRA HOSPITAL   (Singapore)

^b SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

cumulative; early; L thyroxine; late; thyrotoxicosis

Indexed keywords

IODINE 131; LEVOTHYROXINE;

ADOLESCENT; ADULT; AGED; ARTICLE; DRUG EFFICACY; FEMALE; HUMAN; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; MALE; THYROTOXICOSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHI-SQUARE DISTRIBUTION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPOTHYROIDISM; INCIDENCE; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; PREVALENCE; PROGNOSIS; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; RISK FACTORS; THYROTOXICOSIS;

EID: 0030999109     PISSN: 03044602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Yeo P P B, Thai A C, Hughes K, et al. Thyroid disease in Singapore J Med Assoc Thai 1986, 69(Suppl 3):48.
2. Tan C E, Wang K W, Chew L S, Rajasoorya C, Lim H S Manifestations and outcome of treatment of thyrotoxicosis A clinical study. Ann Acad Med Singapore 1990; 19.798-801.
3. Spencer R P, Chapman C N, Rao H. Thyroid carcinoma after radioiodine therapy for hyperthyroidism. analysis based on age, latency, and administered dose of I-131 J Nucl Med 1983; 8.216-9
4. Hall P, Boice J D, Berg G, Bjelkengren G, Ericsson U B, Hallquist A, et al. Leukaemia incidence after iodine-131 exposure Lancet 1992; 340:1-4
5. Sheppard M C Radioiodine therapy for thyrotoxicosis and risk of malignancy. In: Smales R E, editor. Iodine Prophylaxis Following Nuclear Accidents. London Pergamon Press, 1988:111-8.
6. Safa A N, Schmacher O P, Rodriguez A A. Long-term follow-up results in children and adolescents treated with radioactive iodine for hyperthyroidism. N Engl J Med 1975, 292.167-71.
7. Robertson J S, Gorman C A Gonadal radiation dose and its genetic significance in radioiodine therapy for hyperthyroidism. J Nucl Med 1976, 17:826-35.
8. Orgiazzi J Thyroid autoimmune diseases. Endocrinol Metab Clin North Am 1987, 16:374-8
9. Goldsmith R. Radioisotope therapy for Graves' disease Mayo Clin Proc 1972; 47 953-61
10. McDougall R, Greig W R, Gillespie F C. Radioactive iodine therapy for thyrotoxicosis. N Engl J Med 1971, 285 1099-104.
11. Franklyn J, Sheppard M Radioiodine for hyperthyroidism BMJ 1992, 305.727-8
12. Shapiro B. Optimization of radioiodine therapy of thyrotoxicosis: What have we learned after 50 years? J Nucl Med 1993; 34.1638-40
13. Sridama V, McCormick M, Kaplan E L, Fauchet R, DeGroot L J Long-term follow-up of compensated low-dose I-131 therapy for Graves' disease. N Engl J Med 1984; 311 426-31.
14. Kendall-Taylor P, Keir M J, Ross W M. Ablative radioiodine therapy for hyperthyroidism long term follow up study. BMJ 1984, 289 361-3
15. Sundram F X Radioiodine treatment of hyperthyroidism and subsequent hypothyroidism. Singapore Med J 1984, 25:316-9